Brian Piper Prelude Therapeutics Inc (PRLD) insider trading activity

PRLD Quotes by TradingView

Brian Piper is Chief Financial Officer of Prelude Therapeutics Inc. Currently has a direct ownership of 0 shares of PRLD, which is worth approximately $0. The most recent transaction as insider was on Aug 25, 2021, when has been sold 8,333 shares (Common Stock) at a price of $33.33 per share, resulting in proceeds of $277,739. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Brian Piper Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2021
SELL
Open market or private sale
$277,739 $33.33 p/Share
8,333 Reduced 100.0%
0 Common Stock
Aug 25 2021
BUY
Exercise of conversion of derivative security
$15,749 $1.89 p/Share
8,333 Added 50.0%
8,333 Common Stock
May 25 2021
SELL
Open market or private sale
$289,905 $34.79 p/Share
8,333 Reduced 100.0%
0 Common Stock
May 25 2021
BUY
Exercise of conversion of derivative security
$15,749 $1.89 p/Share
8,333 Added 50.0%
8,333 Common Stock
BP

Brian Piper

Chief Financial Officer
Wilmington, DE

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if

News

Receive news related to Prelude Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRLD